Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,24226,140,0.55 [0.30-0.99],0.0453106671871254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27780,151,0.72 [0.53-0.98],0.0340242348920957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,23445,136,1.39 [1.07-1.79],0.0118707269100374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23526,136,0.50 [0.29-0.87],0.0143145929920864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,24214,140,0.51 [0.30-0.86],0.0112373845763686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,23591,137,0.55 [0.32-0.96],0.0354083096848215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,24042,142,0.54 [0.35-0.84],0.0053922783609677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,24261,142,0.46 [0.23-0.90],0.0235691333249017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,24261,142,0.60 [0.37-0.98],0.0423318172543029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,27743,153,0.79 [0.64-0.98],0.0323652720167883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,24175,141,0.78 [0.61-0.98],0.0360594651823013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,27874,155,0.50 [0.33-0.77],0.0017113136876447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,23983,142,0.54 [0.37-0.80],0.0020491718459797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,23526,136,0.68 [0.47-0.99],0.0438845611976724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24214,140,0.53 [0.29-0.95],0.0319519340856408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,24212,142,0.82 [0.68-0.99],0.035865800671057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,28118,155,0.66 [0.45-0.97],0.0355115196336713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,27225,150,0.67 [0.49-0.91],0.010003907400576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,23760,138,1.68 [1.15-2.45],0.0074355217102449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,27099,148,0.68 [0.48-0.96],0.0260580179996718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,24261,142,0.41 [0.20-0.84],0.0150944629621709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,27826,155,0.64 [0.46-0.90],0.0101955182935801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,23008,135,0.48 [0.30-0.75],0.0015971474714297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,28068,153,1.29 [1.04-1.60],0.0184399132026811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23591,137,1.30 [1.02-1.67],0.0354419971105964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,27646,152,0.76 [0.59-0.99],0.044197279821091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,23760,138,0.66 [0.46-0.94],0.0207410218673216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,23526,136,0.47 [0.31-0.70],0.0002490491028694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,24212,142,0.48 [0.32-0.72],0.0003834053256872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,27782,151,1.56 [1.04-2.34],0.0315802742196001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,27909,153,0.68 [0.47-0.99],0.0438939965074948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,23526,136,0.48 [0.32-0.72],0.0004045916037863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,27779,151,0.66 [0.48-0.90],0.0096560839322318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,27544,152,0.75 [0.57-0.99],0.0409955062634893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,23335,137,0.62 [0.39-0.99],0.0444535816735119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,27657,152,0.58 [0.36-0.92],0.019690320051251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27831,151,0.56 [0.33-0.95],0.0300722086459704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,28070,155,0.73 [0.57-0.93],0.0126526604214413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,23335,137,0.61 [0.39-0.95],0.0293954938747615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27691,151,0.81 [0.70-0.95],0.0091018837293649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,27269,150,0.60 [0.38-0.95],0.027981428583225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,28018,153,0.86 [0.74-1.00],0.0484186484079178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,23674,139,0.44 [0.20-0.96],0.0380277422124438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,27099,148,1.27 [1.02-1.59],0.0315568105062341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,27739,151,0.64 [0.47-0.89],0.0070581860532252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,24214,140,0.65 [0.45-0.93],0.0192555483925501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,24212,142,0.49 [0.24-0.97],0.0398559316941905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,28118,155,0.69 [0.54-0.88],0.0025558313576665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,28118,155,0.75 [0.58-0.96],0.0252263060724072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,24209,142,0.45 [0.22-0.91],0.0256134134666507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,23335,137,0.46 [0.23-0.90],0.0233652895300874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,27269,150,1.18 [1.06-1.30],0.0017088002550272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,23445,136,1.27 [1.11-1.45],0.0004070134756489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,27785,151,0.75 [0.60-0.94],0.011742255285044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,28071,155,0.46 [0.25-0.85],0.0128917244420152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,23335,137,0.71 [0.54-0.93],0.0129508701139558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,27780,151,0.56 [0.36-0.87],0.0109273859296765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,23430,140,1.27 [1.00-1.60],0.0485625820000816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,23536,141,0.62 [0.40-0.97],0.0381390439845135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,23702,141,0.50 [0.27-0.92],0.0266503775644795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,28018,153,0.77 [0.61-0.97],0.0287767055755307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,23335,137,0.59 [0.38-0.91],0.0166816004062014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,24158,142,0.77 [0.60-0.99],0.0432917512068012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,27545,150,0.74 [0.58-0.94],0.0155193617352421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,24175,141,1.85 [1.20-2.85],0.0056165829318967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,27099,148,0.79 [0.65-0.97],0.0225174847997031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24077,140,0.47 [0.29-0.75],0.00147227731843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,24077,140,0.67 [0.46-0.99],0.0452997696953116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,27963,153,1.75 [1.14-2.67],0.0103490014867301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,24077,140,0.60 [0.40-0.91],0.0157696698346768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,24088,141,0.31 [0.17-0.55],6.113815233301767e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,22362,133,1.43 [1.05-1.94],0.021597093287227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27964,153,0.58 [0.35-0.95],0.0307730333164467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,23335,137,0.53 [0.30-0.94],0.0307497951622615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24077,140,0.58 [0.37-0.91],0.0176705734770591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,24226,140,0.49 [0.28-0.86],0.012888409253877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,27735,151,0.59 [0.36-0.97],0.037628068784362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,27734,152,0.62 [0.46-0.85],0.0026972881895091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,24177,140,0.74 [0.60-0.93],0.0093811145004026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,27224,148,0.77 [0.59-1.00],0.0487779686107935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,27784,153,0.67 [0.52-0.87],0.0021458288799481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,24158,142,0.50 [0.32-0.77],0.0018694632407266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,27877,155,0.58 [0.39-0.87],0.0084714073979164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23430,140,1.25 [1.03-1.52],0.0274135543342734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,27917,151,1.31 [1.05-1.65],0.0178805391871116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23335,137,0.52 [0.28-0.97],0.0395137924816632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,24116,142,0.78 [0.62-0.98],0.0340537206107574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,24165,140,0.69 [0.49-0.98],0.0381812144792178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,27657,152,0.89 [0.80-0.99],0.0264044242125018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",24083,139,0.56 [0.31-0.99],0.0457268601466262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,23702,141,0.44 [0.24-0.81],0.0081937674917378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,23878,140,0.83 [0.70-0.98],0.030773418235318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,28012,153,1.65 [1.15-2.35],0.006369350762094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",27877,155,0.79 [0.62-1.00],0.049165019879007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,28118,155,0.41 [0.23-0.73],0.0023833202787494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,27734,152,0.60 [0.38-0.92],0.0206339598293822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,23526,136,1.24 [1.07-1.44],0.0053092067595273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,23335,137,0.76 [0.59-0.97],0.0306907666687988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,27780,151,0.51 [0.31-0.84],0.0084468232191726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,24214,140,0.81 [0.66-1.00],0.0457881998365713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,23430,140,0.53 [0.31-0.93],0.0273198086300376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,23335,137,1.39 [1.03-1.88],0.0288265199628622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,27047,148,0.69 [0.48-0.99],0.0449390915807163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24175,141,1.41 [1.08-1.85],0.01125340660794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,24158,142,0.75 [0.60-0.95],0.0152618745752915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,23526,136,0.30 [0.11-0.82],0.0193992217932938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,23702,141,0.43 [0.27-0.68],0.0003615936007106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,27784,153,0.47 [0.26-0.84],0.0106448556349647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,23526,136,0.65 [0.47-0.90],0.008503250310554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,27602,152,0.60 [0.36-1.00],0.049530858682734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,27877,155,0.40 [0.27-0.59],7.047190942187301e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,27224,148,0.52 [0.32-0.84],0.0077898334970677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24261,142,0.36 [0.15-0.84],0.0174944703210842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24077,140,0.66 [0.44-1.00],0.0483553744461279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,23335,137,0.60 [0.38-0.95],0.0303715319307652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,23702,141,0.59 [0.41-0.85],0.0043322920205494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,23430,140,1.29 [1.04-1.60],0.0228126664135448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,23708,140,0.66 [0.44-0.99],0.046359993379213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,24212,142,0.69 [0.52-0.90],0.006787112806049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,23771,139,0.50 [0.26-0.94],0.0315850249390034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",23445,136,1.45 [1.01-2.09],0.0463594909661274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,23532,137,0.42 [0.19-0.91],0.028854224665943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,24212,142,0.48 [0.33-0.71],0.0002077158907179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,22872,130,0.68 [0.52-0.88],0.0036178196268547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,24261,142,0.41 [0.23-0.76],0.0043542759778756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27735,151,0.48 [0.31-0.76],0.0015662401606176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,23430,140,0.69 [0.51-0.94],0.0177434809137502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),23661,140,0.91 [0.83-0.99],0.034145818151613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23536,141,0.61 [0.40-0.95],0.0286895175807641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24175,141,0.49 [0.25-0.94],0.0315633477554458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,24077,140,1.43 [1.04-1.98],0.029108864007129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,27544,152,0.63 [0.40-1.00],0.048794545754658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,28118,155,1.40 [1.09-1.80],0.0082794197454255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,27782,151,1.76 [1.21-2.57],0.0032634929444197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,28028,155,0.41 [0.20-0.83],0.0138917744749065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,23526,136,0.57 [0.34-0.98],0.040121055983249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,24027,140,0.68 [0.46-0.99],0.0439649540549137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,27269,150,0.72 [0.54-0.96],0.0250983169175639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24158,142,1.54 [1.04-2.27],0.0306344233078357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",24214,140,1.57 [1.28-1.93],1.193540705708971e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,24212,142,0.83 [0.72-0.96],0.0131387381366283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,23591,137,1.57 [1.26-1.95],4.66489331832556e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,23445,136,1.40 [1.04-1.87],0.0269513245977822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,23702,141,1.54 [1.30-1.81],4.234093168692753e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,27879,151,0.74 [0.55-0.98],0.0372076724231139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,28018,153,0.56 [0.39-0.81],0.002229940870947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24088,141,0.82 [0.69-0.99],0.040145955730664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,27010,147,3.41 [2.83-4.10],4.630984271305675e-38
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,27917,151,0.59 [0.35-0.99],0.0448556755431449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,27269,150,0.89 [0.80-0.98],0.0190105505999681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,24212,142,0.57 [0.35-0.94],0.0275231103418448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,27780,151,0.49 [0.31-0.78],0.002671435356946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,27784,153,0.54 [0.32-0.90],0.0176857368979052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,27734,152,0.63 [0.42-0.96],0.0307384397443975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,27780,151,0.82 [0.71-0.96],0.011191224247059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,27655,155,0.65 [0.45-0.95],0.0252048094273617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,23702,141,0.58 [0.41-0.82],0.0022629758280586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24088,141,0.38 [0.20-0.71],0.0023249448334566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,28118,155,0.82 [0.68-1.00],0.0453892966686774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,24212,142,0.73 [0.55-0.96],0.0250513754690458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23335,137,0.54 [0.33-0.88],0.0134299904165644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23526,136,0.63 [0.41-0.98],0.0400921712712104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,27784,153,0.57 [0.35-0.92],0.0227112701620123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,24084,142,0.84 [0.71-0.99],0.0392741028071911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,23627,139,0.48 [0.24-0.98],0.0445588604267964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,27127,147,0.57 [0.34-0.98],0.0402031622413768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24158,142,0.76 [0.62-0.94],0.0116410505365234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,27877,155,0.54 [0.33-0.91],0.0203898769480899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,24212,142,0.62 [0.40-0.96],0.0323143430486919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,24084,142,0.79 [0.66-0.95],0.0127903943048824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24212,142,0.73 [0.55-0.98],0.034634696906079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,27127,147,0.71 [0.52-0.96],0.0284705538352024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,23532,141,0.76 [0.59-0.97],0.028550915737632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,27874,155,0.71 [0.53-0.95],0.019718411803824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,23526,136,0.68 [0.48-0.98],0.0405166231705088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,28118,155,0.53 [0.33-0.86],0.0100643784486688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24088,141,0.41 [0.17-0.97],0.0434375755781935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,27224,148,0.78 [0.63-0.96],0.0181991571234961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,27657,152,0.82 [0.67-0.99],0.044192955840471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,24077,140,0.35 [0.15-0.81],0.014726148999355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,27657,152,0.63 [0.43-0.90],0.012705267155332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,27657,152,0.51 [0.31-0.85],0.0093590903940038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,27831,151,0.58 [0.38-0.88],0.0099171526941521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,27869,151,0.76 [0.63-0.93],0.0065224447351575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,27224,148,0.63 [0.45-0.89],0.0094298023830247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,27780,151,0.63 [0.43-0.94],0.0236529194075011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,27780,151,0.71 [0.53-0.97],0.0296670862275132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,28118,155,0.74 [0.56-0.98],0.0334643832058118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,27874,155,0.76 [0.59-0.97],0.0305268537117749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,24175,141,0.75 [0.59-0.95],0.0178131420858979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,28118,155,0.80 [0.65-0.98],0.029629297250712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,24214,140,0.66 [0.51-0.86],0.0017637985011976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,27877,155,0.56 [0.34-0.94],0.0274350608221361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,27834,155,0.73 [0.54-1.00],0.0478407392406953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,23526,136,0.46 [0.27-0.77],0.0032609437070324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,23760,138,1.29 [1.13-1.48],0.0002399971051179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,24175,141,1.38 [1.04-1.85],0.0269414038017758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,24158,142,0.47 [0.27-0.84],0.0105914538807228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28118,155,0.60 [0.36-0.99],0.0463699075146063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23335,137,0.73 [0.54-0.98],0.0385612719316907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28018,153,0.70 [0.54-0.90],0.0055304316459692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,24088,141,0.55 [0.33-0.92],0.0236256933224508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,23335,137,0.69 [0.52-0.92],0.0126112556418745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24077,140,0.63 [0.40-0.99],0.0442977324943729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,27269,150,1.18 [1.03-1.35],0.0159898844777238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,24214,140,0.54 [0.32-0.93],0.0264576963584705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,27269,150,0.58 [0.39-0.85],0.0055850029982699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27874,155,1.38 [1.01-1.89],0.0439199382027267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27835,153,0.72 [0.55-0.95],0.0193017548010634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,27586,152,0.71 [0.51-1.00],0.0495160517985785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,24214,140,0.43 [0.24-0.77],0.0042769427745874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,24212,142,0.79 [0.64-0.97],0.0225063866122089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,24226,140,0.69 [0.50-0.95],0.0212332194427227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,23445,136,0.64 [0.42-0.96],0.0300225184424002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,23445,136,1.36 [1.07-1.72],0.0116119573963911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,24212,142,0.82 [0.68-1.00],0.0492428844717557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,27780,151,0.57 [0.35-0.95],0.0311791902706876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,24077,140,0.37 [0.22-0.61],0.0001183950038135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,28018,153,0.55 [0.34-0.89],0.0141200218927671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,23335,137,0.66 [0.51-0.87],0.0027984962203244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,23526,136,0.50 [0.28-0.91],0.0224555360655252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,24175,141,0.58 [0.34-0.99],0.0442640833274221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,24077,140,0.58 [0.34-0.99],0.0471523982893083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27739,151,0.78 [0.61-1.00],0.0480972966974557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,27963,153,0.68 [0.48-0.96],0.0298129006261659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,23335,137,0.58 [0.41-0.81],0.0012994619211123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,24077,140,0.57 [0.34-0.95],0.0314535179158575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27504,151,1.51 [1.07-2.11],0.0174675799716047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,28012,153,0.62 [0.41-0.95],0.0267027316107076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,23526,136,0.48 [0.26-0.90],0.0226763363539111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,24088,141,0.77 [0.60-0.99],0.0426316615811775
